A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin ...

Isomorphic Labs, backed by Google's parent company Alphabet, is preparing for its first human clinical trials for cancer drugs designed entirely by artificial intelligence.

The company was spun out of Google DeepMind in 2021 ... In a recent interview with Fortune, Isomorphic Labs President Colin Murdoch said the company is “very close” to starting clinical trials. “There ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...

A Isomorphic Labs, a drug discovery company driven by artificial intelligence (IA) and part of the A (holding of Google), is ...

What was it like to track the rising danger of this asteroid, and to ultimately determine that it’d miss us? This is the ...

Meta unsuccessfully tried to poach Dr Koray Kavukcuoglu, one of Google’s top AI researchers, as well as Dr Noam Brown, a leading researcher at OpenAI, according to a person familiar with the effort.

Meta has poached top engineers from multiple tech firms, including Google, for a new team focused on achieving a more advanced form of AI called artificial general intelligence.